Skip to main content

Weaver C. Barksdale & Associates, Inc.

Position in ABBV — AbbVie Inc.

CIK 1294588 NASHVILLE, TN

Position in ABBV

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$2,490,732
+$335,624 QoQ
Shares Held
9,898
-0.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
2.23%
of 13F equity value
Holder Rank
#1,788
of 4,153 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ABBV Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Weaver C. Barksdale & Associates, Inc. holds $10,562,339 across 6 Drug Manufacturers - General names. ABBV ranks #1 (23.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ABBV
AbbVie Inc.
This page
9,898 $2,490,732

All Filings in ABBV

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,490,732 9,898
2026-03-31 $2,155,108 9,909
2025-12-31 $2,124,728 9,299
2025-09-30 $2,415,193 10,431
2025-06-30 $2,056,483 11,079
2025-03-31 $2,342,433 11,180
2024-12-31 $2,032,177 11,436
2024-09-30 $2,312,885 11,712
2024-06-30 $2,082,767 12,143
2024-03-31 $2,245,657 12,332
2023-12-31 $1,926,122 12,429
2023-09-30 $2,317,883 15,550
2023-06-30 $1,746,370 12,962
2023-03-31 $2,191,178 13,749
2022-12-31 $2,329,931 14,417
2022-09-30 $1,886,187 14,054
2022-06-30 $2,228,784 14,552
2022-03-31 $2,919,438 18,009
2021-12-31 $2,404,704 17,760